Skip to content
Screener

Ardent Health Partners ARDT Q4 2025 Annual earnings

Reported March 4, 2026 · After market close

Revenue$1.6BMiss by $26.1M
EPS$0.32Miss by $0.03
Revenue estimate$1.6B
EPS estimate$0.35

Next report

Nov 11, 2026 (in a month)
Revenue estimate$1.6B
EPS estimate$0.24

Financials

Q4 2025

Income statement

See full
Revenue$1.6B-0.1%
Gross profit$1.6B-0.3%
Net income$45.0M-60.6%
EPS (diluted)$0.32-61.9%

Balance sheet

See full
Cash & equivalents$709.6M+27.4%
Total debt$2.4B+2.3%
Total equity$1.3B+13.8%
Total assets$5.3B+6.7%

Cash flow

See full
Operating cash flow$223.4M+86.9%
CapEx$84.0M+3.3%
Free cash flow$139.4M+264%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$1.26B-48.1%
Enterprise value$2.92B-30.4%
P/E9.3×-2.3×
P/S0.2×-0.2×

Profitability

See full
Gross margin97.5%0.0pp
Net margin2.1%-1.4pp
FCF margin4.1%+2.0pp

Returns & leverage

See full
Return on equity11.2%-12.1pp
Debt / equity1.8×-0.2×
Current ratio2×0.0×

Segments

By segment

See full
Reportable Segment$1.6B-0.1%

FAQ

When did Ardent Health Partners report Q4 2025 earnings?
Ardent Health Partners (ARDT) reported Q4 2025 earnings on March 4, 2026 after market close.
What were Ardent Health Partners's Q4 2025 revenue and EPS?
Ardent Health Partners reported revenue of $1.6B and eps of $0.32 for Q4 2025.
Did Ardent Health Partners beat estimates in Q4 2025?
Revenue missed the consensus estimate of $1.6B by $26.1M. EPS missed the consensus estimate of $0.35 by $0.03.
How did Ardent Health Partners's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 0.1% from $1.6B a year earlier and eps declined 60.5% from $0.81.
Where can I find Ardent Health Partners's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001628280-26-014640) and the 10-K periodic report (0001628280-26-018174) directly on SEC EDGAR. The filing index links above go to sec.gov.